Skip to main content
. 2023 Jul 1;23:337. doi: 10.1186/s12872-023-03312-w

Table 2.

Lipid levels at admission and at the 6-month follow-up

Characteristic/category All patients (n = 252) No pre-LLT patients (n = 180) LLT patients (n = 72) P-value*
Lipid levels at admission, mean ± SD (mmol/L)
TC 4.2 ± 1.1 4.3 ± 1.1 3.8 ± 1.0 < 0.001
LDL-C 2.6 ± 0.9 2.7 ± 1.0 2.3 ± 0.8 0.002
HDL-C 1.0 ± 0.3 1.0 ± 0.3 1.0 ± 0.2 0.141
TG 2.0 ± 1.8 2.1 ± 2.0 1.6 ± 0.9 0.051
Lipid levels at 6-month follow-up, mean ± SD (mmol/L)
TC 3.1 ± 1.6 3.1 ± 1.5 3.1 ± 1.6 0.834
LDL-C 1.7 ± 1.0 1.7 ± 1.0 1.7 ± 1.0 0.481
HDL-C 0.9 ± 0.5 0.9 ± 0.5 0.9 ± 0.5 0.744
TG 1.5 ± 1.7 1.5 ± 1.9 1.3 ± 1.1 0.619
LDL-C < 1.4 mmol/L at admission 0.821
No 233 (92.5%) 166 (92.2%) 67 (93.1%)
Yes 19 (7.5%) 14 (7.8%) 5 (6.9%)
LDL-C < 1.4 mmol/L at 6-month follow-up 0.491
No 174 (69.0%) 122 (67.8%) 52 (72.2%)
Yes 78 (31.0%) 56 (31.5%) 20 (27.8%)

TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides

*P-value compared between the no pre-LLT group and the LLT group